“Should Runners Be Worried About Colon Cancer?,” Runner’s World, September 19, 2025
While endurance running is widely celebrated for its health benefits, a trailblazing study led by Tim Cannon, MD, Sheridan Director of the Molecular Tumor Board and Co-Director of the Gastrointestinal Cancer Program at Inova Schar Cancer, reveals a surprising link to colon cancer risk. Featured in Runner’s World, the research opens important conversations around screening guidelines and reinforces the importance of proactive health monitoring, regardless of one’s fitness level.
Article links: